Applied Clinical Research, Clinical Trials and Regulatory Affairs

The rays of regulations those oversee health care can appear awe-inspiring. Almost every single facet of this field is supervised by one regulatory body. The latitude and complexity of health care regulation is the theme of this issue. We expect articles those describes fundamental logic behind the mystifying regulatory network, recent advancement, suggestions, critiques, case lets as well as strategic interventions of regulatory aspect. It can be always awe-inspiring to know and understand all the dynamic regulations that spread on the health care industry. On the top of it, it’s more interesting to identify which regulatory agency is accountable for the implementation/enforcement of firmnecessities and how it happens as per current move. No one will deny because Regulation plays a major role in the health care industry and health care industry is mostly driven with health care insurance coverage. The various regulatory bodies guard the community from a number of health risks. So, these regulatory agencies not only protect but also control public health neck and neck at every stage. Health care guidelines, values and standards are always necessary to ensure compliance and to provide safe health care to each and every individual who accesses the medicines. The health care regulatory agencies in turn monitor practitioners and facilities, provide information about industry changes, promote safety and ensure legal compliance and quality services. We're interested in original research, viewpoints, short communication, case studies projected for regulatory traits/environment of Pharmaceuticals, Medical devices, Biological and biotechnology products, cosmetics, veterinary products, Nutraceuticals, Food supplements, Health maintenance organizations (HMOs), Hospital management firms and Medical and dental practice activities of particular interests dealing with "REGULATORY TRAITS - RELEVANCE TO CONTEMPORARY HEALTHCARE ENVIRONMENT”.

The rays of regulations those oversee health care can appear awe-inspiring. Almost every single facet of this field is supervised by one regulatory body. The latitude and complexity of health care regulation is the theme of this issue. We expect articles those describes fundamental logic behind the mystifying regulatory network, recent advancement, suggestions, critiques, case lets as well as strategic interventions of regulatory aspect. It can be always awe-inspiring to know and understand all the dynamic regulations that spread on the health care industry. On the top of it, it’s more interesting to identify which regulatory agency is accountable for the implementation/enforcement of firmnecessities and how it happens as per current move. No one will deny because Regulation plays a major role in the health care industry and health care industry is mostly driven with health care insurance coverage. The various regulatory bodies guard the community from a number of health risks. So, these regulatory agencies not only protect but also control public health neck and neck at every stage. Health care guidelines, values and standards are always necessary to ensure compliance and to provide safe health care to each and every individual who accesses the medicines. The health care regulatory agencies in turn monitor practitioners and facilities, provide information about industry changes, promote safety and ensure legal compliance and quality services. We're interested in original research, viewpoints, short communication, case studies projected for regulatory traits/environment of Pharmaceuticals, Medical devices, Biological and biotechnology products, cosmetics, veterinary products, Nutraceuticals, Food supplements, Health maintenance organizations (HMOs), Hospital management firms and Medical and dental practice activities of particular interests dealing with "REGULATORY TRAITS - RELEVANCE TO CONTEMPORARY HEALTHCARE ENVIRONMENT”.

Major advances in nano-based pharmaceuticals and cosmetics have resulted in breakthrough developments in improving the health and skin care. The convergence of nanotechnology with pharmaceuticals and cosmetics is transforming the health and beauty care sector with several nano-based products in the market or in clinical testing. It is thus mandatory to assess the regulatory laws for the management of potential risks posed (both human and environmental) by such nanoproducts. Their toxicity profile needs to be well addressed and respective regulatory framework to be developed and reinforced by the authorities. In view of the potentially immense commercial and societal benefits that may come from nanotechnology, it is likely that nanomaterials, and products and applications containing them, are being widely investigated, produced and used; but nanotechnology has also brought new and heightened risks that have not been fully confiscated. Scientists, clinicians and regulators together have to work on the global harmonization and amend the present regulatory guidelines to remove the risks posed by the nano-based formulations if any. The regulatory analysts must review the existing legal mechanisms and determine the adequacy and efficiency in protecting the safety of consumers. This special issue contains the regulatory overview of the nanopharmaceuticals and nanocosmetics, and their quality and safety aspects per se.

Major advances in nano-based pharmaceuticals and cosmetics have resulted in breakthrough developments in improving the health and skin care. The convergence of nanotechnology with pharmaceuticals and cosmetics is transforming the health and beauty care sector with several nano-based products in the market or in clinical testing. It is thus mandatory to assess the regulatory laws for the management of potential risks posed (both human and environmental) by such nanoproducts. Their toxicity profile needs to be well addressed and respective regulatory framework to be developed and reinforced by the authorities. In view of the potentially immense commercial and societal benefits that may come from nanotechnology, it is likely that nanomaterials, and products and applications containing them, are being widely investigated, produced and used; but nanotechnology has also brought new and heightened risks that have not been fully confiscated. Scientists, clinicians and regulators together have to work on the global harmonization and amend the present regulatory guidelines to remove the risks posed by the nano-based formulations if any. The regulatory analysts must review the existing legal mechanisms and determine the adequacy and efficiency in protecting the safety of consumers. This special issue contains the regulatory overview of the nanopharmaceuticals and nanocosmetics, and their quality and safety aspects per se.

No Text Found

No Text Found